FIELD: medicine.SUBSTANCE: invention relates to a method for reducing or alleviating seizures in a patient diagnosed with refractory epilepsy, or Dravet's syndrome, said method comprising administering fenfluramine and cannabidiol, thereby modulating synthesis of norfenfluramine, wherein synthesis of norfenfluramine is reduced leading to higher levels of fenfluramine.EFFECT: reduced dosage of the first medicinal product with maintained efficiency equivalent to that of higher doses of the first medicinal product when administered as monotherapy.10 cl, 7 dwg, 4 ex
COMPOSITION FOR INHIBITING SYNTHESIS OF 5-HT2B AGONIST AND METHODS OF USE THEREOF